基线FDG PET总代谢肿瘤体积对Richter综合征的预后价值
回顾性分析28例慢性淋巴细胞白血病转化为弥漫大B细胞淋巴瘤(Richter综合征)患者,治疗前FDG PET测得的总代谢肿瘤体积(TMTV)在单因素分析中与总生存期显著相关,低代谢负荷组(TMTV≤1200 cm)5年OS为63%,高代谢负荷组(TMTV>1200 cm)为0%,但多因素分析仅高LDH为独立预测因子。
要点
- TMTV>1200 cm的患者5年总生存率为0%,TMTV≤1200 cm者为63%。
- 单因素分析中低血小板、WHO体能状态评分>1、高LDH和高TMTV与OS显著相关。
- 多因素分析校正后仅高LDH是OS的显著独立预测因子。
核心结论
- 在CLL转化为DLBCL时,FDG PET提取的TMTV是总生存期的预测因素。
研究设计与样本
- 回顾性纳入28例治疗前接受FDG PET的CLL转化为DLBCL患者。
- 对常规临床病理变量和代谢参数(SUVmax、SUVmean、TMTV、总病灶糖酵解)进行单因素和多因素分析,终点为总生存期。
主要发现
- 28例患者中14例(50%)在随访期间死亡。
- 单因素分析显示低血小板计数、WHO体能状态评分>1、高LDH和高TMTV是OS的显著预后因素。
- 低代谢负荷组(TMTV≤1200 cm)5年OS估计值为63%,高代谢负荷组(TMTV>1200 cm)为0%。
- 多因素分析校正其他变量后,仅高LDH是OS的显著预测因子。
关键数值与推荐
- TMTV分组阈值为1200 cm,低代谢负荷组为TMTV≤1200 cm,高代谢负荷组为TMTV>1200 cm。
- 低代谢负荷组5年OS估计值为63%,高代谢负荷组为0%。
临床怎么用
- 在Richter综合征患者治疗前可考虑通过FDG PET测量TMTV以辅助预后分层。
- TMTV>1200 cm提示预后极差,5年OS估计为0%,可支持更密切的随访或强化治疗决策。
- LDH升高是多因素分析中唯一的独立预后因素,应结合LDH综合评估。
局限性
- 回顾性研究,样本量仅28例。
- 多因素分析中TMTV未保持独立预后意义,仅高LDH为显著预测因子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the prognostic value of baseline total metabolic tumor volume (TMTV) measured using pretreatment FDG PET for patients with transformation of chronic lymphocytic leukemia (CLL) into diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 28 patients with transformation of CLL into DLBCL who had undergone FDG PET before treatment were retrospectively reviewed. Univariate and multivariate analysis of conventional clinicopathologic variables (sex, age, World Health Organization performance status score, International Prognostic Index score, Binet stage, lactate dehydrogenase serum level [LDH], platelet count, presence or not of prior therapies for CLL, the time from CLL to Richter syndrome, Ann Arbor stage, Bulky or not) and metabolic parameters (SUVmax, SUVmean, TMTV, and total lesion glycolysis) at the time of the transformation of CLL into DLBCL were tested for overall survival (OS). RESULTS: Of the 28 patients, 14 patients (50%) died during the follow-up period. Low platelet count, World Health Organization performance status score >1, high LDH, and high TMTV were found to be significant prognostic factors for OS on univariate analysis. The 5-year estimates of OS were 63% in the low metabolic burden group (TMTV ≤1200 cm) and 0% in the high metabolic burden group (TMTV >1200 cm). Multivariate analysis revealed that only high LDH was a significant predictor after adjustment for other variables of OS. CONCLUSIONS: TMTV extracted from FDG PET at the time of the transformation of CLL into DLBCL is a predictor of OS.
引用
- Pontoizeau C, Girard A, Mesbah H, et al. Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome. Clin Nucl Med. 2020. PMID: 31876819. doi:10.1097/RLU.0000000000002879
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。